First patient treated in U.S.-approved embryonic stem cell trial
The first patient to be treated in a U.S.-government-approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells.
The patient, being cared for at the Shepherd Center in Atlanta, is partially paralyzed following a spinal cord injury. The center specializes in treating these types of injuries.
According to the trial's protocol, patients must receive the stem cell injection within 14 days of the injury. The trial only involves patients with spinal cord injuries.
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- A Fresh Look at End-of-Life Care
- 3 in 4 Patients Want E-mail Consultations
- Heart Attack Patient Costs Skyrocket Beyond 30 Days
- 3 Insider Tips on Cutting Costs without Strangling Growth
- ACGME Chief Sees 'Huge' Risk of Error in Proposed Assistant Physician Licensure
- Centralizing the Revenue Cycle Protects the Bottom Line
- 4 Tectonic Shifts Shaking Up Healthcare